Renal Insufficiency  >>  odanacatib (MK-0822)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
odanacatib (MK-0822) / Merck (MSD)
NCT01512667: Pharmacokinetic Assessment of Single-Dose Odanacatib (MK-0822) in Subjects With Severe Renal Insufficiency (MK-0822-067)

Completed
1
25
NA
MK-0822, odanacatib
Merck Sharp & Dohme LLC
Renal Insufficiency
08/12
08/12

Download Options